On March 21, Wondfo Biotech officially signed a Memorandum of Understanding (MOU) with the IFCC Foundation for Emerging Nations (FEN) during CACLP 2026, marking the beginning of a new collaboration aimed at advancing laboratory medicine worldwide.

FEN is devoted to fund raising and to supporting programmes that help to improve the quality and delivery of laboratory medicine services, particularly in emerging nations. Aligned with FEN’s mission, Wondfo and FEN will strengthen cooperation in scientific research and educational initiatives related to laboratory medicine.
 
Prof. Tomris Ozben, President of the IFCC and Member of the FEN Board of Directors, expressed enthusiasm about the collaboration, noting that partnerships between global organizations and industry leaders play an important role in advancing innovation and strengthening the global impact of laboratory medicine.


 
Mr. Mark Xu, Vice President and Head of International Sales & Marketing Center of Wondfo, also highlighted the significance of the partnership. He noted that Wondfo remains committed to advancing diagnostic technologies and looks forward to working closely with FEN to support the development of laboratory medicine worldwide.


 
Wondfo will continue to collaborate with global partners to accelerate innovation and expand access to high-quality diagnostic solutions, contributing to better healthcare for communities around the world.


 

Wondfo has been an official member of the IFCC for many years. Last year, we successfully co-hosted the Global POCT Summit with the IFCC in Guangzhou, bringing together over 200 experts and industry professionals from more than 70 countries. Looking ahead, Wondfo is confident about embarking on even deeper collaborations with the IFCC to build a bright future together!

Learn more：https://en.wondfo.com/news/index322.html